Finance

Senarai
CRSP:NASDAQ
Crispr Therapeutics AG
USD 49.88
-0.32%
(-0.16) 1H
USD 49.89
+0.02% (+0.0099)
Prapasaran
Ditutup: 20 Okt, 4:00:00 PTG GMT-4  ·   USD
Semua simbol
SimbolHargaPerubahan% Perubahan
Menjana cerapan popular untuk CRSP...
Buka
USD 48.87
Tinggi
USD 50.33
Rendah
USD 47.36
Permodalan Pasaran
4.82B
Purata volum
1.67J
Volum
322.00
tgi 52 mgu
USD 75.06
rdh 52 mgu
USD 44.12
EPS
-USD 4.76
Beta
1.45
Syer tertunggak
96.69J
Bilangan pekerja
393
Buka
USD 48.87
Tinggi
USD 50.33
Rendah
USD 47.36
Permodalan Pasaran
4.82B
Purata volum
1.67J
Volum
322.00
tgi 52 mgu
USD 75.06
rdh 52 mgu
USD 44.12
EPS
-USD 4.76
Beta
1.45
Syer tertunggak
96.69J
Bilangan pekerja
393
Cerita berita
Daripada sumber web dan rakan kongsi berita
Profil
CRISPR Therapeutics AG is a Swiss–American biotechnology company headquartered in Zug, Switzerland. The company does business as CRISPR Therapeutics, Inc. in the United States. It was one of the first companies formed to utilize the CRISPR gene editing platform to develop medicines for the treatment of various rare and common diseases. The company has approximately 500 employees and has offices in Zug, Switzerland; Boston, Massachusetts; San Francisco, California; and London, United Kingdom. Its manufacturing facility in Framingham, Massachusetts, won the Facilities of the Year Award award in 2022. The company’s lead program, exagamglogene autotemcel, or exa-cel, was granted regulatory approval by the US Food and Drug Administration in December 2023. Wikipedia
Perihal Crispr Therapeutics AG
CEOSamarth Kulkarni
Pekerja393
Diasaskan2013
Ibu pejabatZug, Zug, Switzerland
Sektor-
Laman webcrisprtx.com
Rating penganalisis
Berdasarkan 14 penganalisis yang memberikan rating saham kepada CRSP dalam tempoh 3 bulan yang lalu
Beli
Beli
8
Pegang
6
Jual
0
Ramalan 12 bulan
Berdasarkan 14 penganalisis Wall Street yang menawarkan sasaran harga 12 bulan untuk CRSP dalam tempoh 3 bulan yang lalu.
Tertinggi
Semasa USD 49.88
USD 110.00 (+120.53%)
Purata
USD 71.85 (+44.05%)
Terendah
USD 45.00 (-9.78%)
Penganalisis
Syor
Tindakan
Sasaran harga
Diunjurkan
Tarikh
Joon Lee
UBS
Hold
Initiated
USD 52.00
+4.3%
10/15/2026
Alec Stranahan
Bank of America Securities
Buy
Maintained
USD 81.00
+62.4%
10/09/2026
Mitchell Kapoor
H.C. Wainwright
Buy
Reiterated
USD 80.00
+60.4%
10/09/2026
Gil Blum
Needham
Buy
Maintained
USD 82.00
+64.4%
10/05/2026
Yanan Zhu
Wells Fargo
Hold
Maintained
USD 75.00
+50.4%
10/02/2026
Yigal Nochomovitz
Citi
Buy
Maintained
USD 88.00
+76.4%
09/04/2026
Jonathan Miller
Evercore ISI
Buy
Maintained
USD 76.00
+52.4%
08/31/2026
Sami Corwin
William Blair
Buy
Maintained
-
-
08/28/2026
Maxwell Skor
Morgan Stanley
Hold
Maintained
USD 60.00
+20.3%
08/28/2026
Salveen Richter
Goldman Sachs
Hold
Reiterated
USD 55.00
+10.3%
08/10/2026
Unknown Analyst
Goldman Sachs
Hold
Maintained
USD 55.00
+10.3%
08/06/2026
Terence Flynn
Morgan Stanley
Hold
Maintained
USD 60.00
+20.3%
08/04/2026
Edward Tenthoff
Piper Sandler
Buy
Reiterated
USD 110.00
+120.5%
08/04/2026
Tyler Van Buren
TD Cowen
Hold
Maintained
USD 45.00
-9.8%
08/03/2026
Luca Issi
RBC Capital
Hold
Maintained
USD 50.00
+0.2%
08/03/2026
Silvan Turkcan
Citizens JMP
Buy
Maintained
USD 80.00
+60.4%
07/22/2026
Unknown Analyst
Mizuho Securities
Buy
Maintained
USD 85.00
+70.4%
06/10/2026
William Pickering
Bernstein
Hold
Reiterated
USD 56.00
+12.3%
05/13/2026
Geulah Livshits
Chardan Capital
Buy
Reiterated
USD 76.00
+52.4%
05/04/2026
Brian Cheng
J.P. Morgan
Buy
Maintained
USD 67.00
+34.3%
02/13/2026
Silvan Tuerkcan
Citizens JMP
Buy
Maintained
USD 80.00
+60.4%
01/30/2026
Laporan sebelumnyaSemua nilai dalam USD
Loading Previous Earnings...
Hasil
Pendapatan bersih
Semua nilai dalam USD
Sep 2025
Dis 2025
Mac 2026
Jun 2026
Hasil
889.00K
864.00K
1.46J
10.18J
Kos barangan yang dijual
116.02J
137.23J
114.52J
107.42J
Kos hasil
116.02J
137.23J
114.52J
107.42J
Perbelanjaan penyelidikan dan pembangunan
-
-
-
-
Jumlah perbelanjaan penyelidikan dan pembangunan
-
-
-
-
Perbelanjaan jualan, am dan pentadbiran
16.93J
18.40J
17.18J
17.55J
Belanja kendalian
16.93J
18.40J
17.18J
17.55J
Jumlah belanja kendalian
132.95J
155.63J
131.71J
124.98J
Pendapatan kendalian
-132.06J
-154.76J
-130.25J
-114.80J
Pendapatan bukan kendalian lain
26.24J
24.76J
8.16J
27.08J
EBT termasuk item luar biasa
-105.82J
-130.00J
-122.09J
-90.19J
EBT tidak termasuk item luar biasa
-105.82J
-130.00J
-122.09J
-87.72J
Belanja cukai pendapatan
619.00K
614.00K
839.00K
960.00K
Kadar cukai berkesan
-0.58%
-0.47%
-0.69%
-1.06%
Belanja kendalian lain
-
-
-
-
Pendapatan bersih
-106.44J
-130.61J
-122.93J
-91.15J
Margin untung bersih
-11,973.12%
-15,117.25%
-8,431.48%
-895.33%
Perolehan bagi setiap syer
-1.17
-1.37
-1.28
-0.94
Pendapatan faedah dan pelaburan
-
-
-
-
Belanja faedah
-
-
-
-
Belanja faedah bersih
-
-
-
-
Caj susut nilai dan pelunasan
-
-
-
-
EBITDA
-127.63J
-149.10J
-125.93J
-110.52J
Keuntungan atau kerugian daripada jualan aset
-
-
-
-
Transaksi orang dalam
Data transaksi orang dalam diperoleh daripada sumber pihak ketiga. Ketahui lebih lanjut
Orang dalam
Jawatan
Jenis
Tarikh
Saham
Jumlah
Halaman 1
Kandungan AI boleh mengandungi kesilapan. Ketahui lebih lanjut
BantuanHantar maklum balasPrivasiSyaratPenafian
Apl Google